Welcome to our dedicated page for Aramark SEC filings (Ticker: ARMK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Aramark (ARMK) filings document a Delaware operating company with NYSE-listed common stock and a business centered on food, facilities management, hospitality, and support services. Its 8-K reports include operating results, material definitive agreements, annual meeting voting results, and compensation matters involving restricted stock units and executive equity awards.
Proxy materials disclose board elections, auditor ratification, executive compensation, equity awards, shareholder voting matters, and governance practices. Financing filings also describe amendments to the credit agreement of Aramark Services, Inc., an indirect wholly owned subsidiary, including term-loan refinancing and repricing transactions within the company’s capital structure.
Lauren A. Harrington, SVP and General Counsel of Aramark (ARMK), was credited with 61.939 shares as dividend equivalent rights related to restricted stock units on 08/20/2025, recorded at a $0 price. After this accrual, the reporting person beneficially owned 96,929.029 shares. The filing states these dividend equivalent rights vest on the same schedules as the underlying restricted stock unit awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Aramark (ARMK) Form 4: Marc A. Bruno, COO U.S. Food & Facilities and an officer of Aramark, reported an acquisition on 08/20/2025. The filing shows 72.048 shares were acquired at $0, described as dividend equivalent rights that vested in connection with the issuer's quarterly dividend and accrued to the reporting person on restricted stock units.
Following the transaction, the reporting person beneficially owns 259,095.274 shares. The Form 4 was signed by an attorney-in-fact on 08/21/2025. The filing indicates these dividend equivalents vest on the same schedule as the underlying restricted stock unit awards.
Aramark (ARMK) Form 4 — insider acquisition via dividend equivalents
Senior Vice President & Chief HR Officer Abigail Charpentier was reported as acquiring 64.783 shares of Aramark common stock on 08/20/2025 at a reported price of $0, described as dividend equivalent rights that vested with underlying restricted stock units. After the transaction, the reporting person beneficially owned 54,056.256 shares. The filing was signed by an attorney-in-fact on 08/21/2025. The entry indicates these are non-cash, compensation-related share credits tied to quarterly dividends and the vesting schedule of the underlying awards.
John J. Zillmer, Director and Chief Executive Officer of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025 of 721.338 shares of Aramark common stock at a reported price of $0. After the transaction the filing lists 832,546.749 shares beneficially owned by the reporting person. The filing states these shares represent dividend equivalent rights that accrued on restricted stock units and vest on the same schedule as the underlying awards.
The Form 4 was signed by an attorney‑in‑fact on 08/21/2025. No cash purchase price was reported because the grant reflects dividend equivalents tied to existing restricted stock units rather than an open‑market purchase or sale.
Greg Creed, a director of Aramark (ARMK), reported a Form 4 disclosing awards that vested on 08/20/2025. The filing records the acquisition of 155.111 dividend equivalent rights related to deferred stock units at a $0 price. Following the transaction, the reporting person beneficially owns 58,282.323 shares directly and 12,475 shares indirectly through a trust. The filing explains these amounts represent dividend equivalents that vest on the same schedule as the underlying deferred stock units.
Karen Marie King, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The filing shows 29.912 shares were acquired at $0 as dividend equivalent rights credited on deferred stock units; these rights vest on the same schedule as the underlying awards. After the transaction, the reporting person beneficially owned 37,614.967 shares directly. The report was signed by an attorney‑in‑fact on 08/21/2025.
Bridgette P. Heller, a director of Aramark (ARMK), reported a non‑derivative acquisition on 08/20/2025. The Form 4 shows 79.515 shares acquired at $0, recorded as dividend equivalent rights that accrued on deferred stock units and vest on the same schedule as the underlying awards. Following the reported transaction, the filing lists 30,416.4 shares beneficially owned in a direct form. The filing was submitted by one reporting person and signed by an attorney‑in‑fact on 08/21/2025. The report includes the reporter's address at Aramark's Philadelphia office.
Patricia E. Lopez, a director of Aramark (ARMK), acquired 62.2 shares on 08/20/2025 through dividend equivalent rights that vested on deferred stock units she holds. The reported transaction shows a $0 per-share price and leaves the reporting person with 23,792.883 shares beneficially owned in a direct form. The filing clarifies these were dividend equivalent rights tied to the issuer's quarterly dividend and that such rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.
Kevin Wills, a director of Aramark (ARMK), reported a Form 4 filing showing an internal award-related acquisition dated 08/20/2025. The filing states 29.129 shares were acquired at $0 as dividend equivalent rights that accrued on deferred stock units held by the reporting person. After the reported transaction the filing shows the reporting person beneficially owning 16,696.312 shares. The filing explains these dividend equivalent rights vest on the same schedule as the underlying awards and were reported by an attorney-in-fact on 08/21/2025.
Stephen I. Sadove, a director of Aramark (ARMK), reported an internal transaction dated 08/20/2025 showing acquisition of 210.525 dividend-equivalent rights related to deferred stock units at a $0 price. After the transaction he beneficially owned 94,042.121 shares directly and 15,000 shares indirectly through a trust. The filing explains these dividend-equivalent rights vest on the same schedule as the underlying awards. The Form 4 was signed by an attorney-in-fact on 08/21/2025.